multiple sclerosis

  1. forestglip

    The phenotypic and genetic association between endometriosis and immunological diseases, 2025, Shigesi et al

    The phenotypic and genetic association between endometriosis and immunological diseases Nina Shigesi, Holly R Harris, Hai Fang, Anne Ndungu, Matthew R Lincoln, The International Endometriosis Genome Consortium, The 23andMe Research Team, Chris Cotsapas, Julian Knight, Stacey A Missmer, Andrew P...
  2. forestglip

    Uncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis, 2025, Baller et al

    Uncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis Erica B. Baller, Audrey C. Luo, Matthew K. Schindler, Elena C. Cooper, Margaret K. Pecsok, Matthew C. Cieslak, Melissa Lynne Martin, Amit Bar-Or, Ameena Elahi, Christopher M. Perrone, Bailey C. Spangler, Theodore D...
  3. forestglip

    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study, 2021, Grut et al

    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study Viktor Grut, Martin Biström, Jonatan Salzer, Pernilla Stridh, Daniel Jons, Rasmus Gustafsson, Anna Fogdell-Hahn, Jesse Huang, Nicole Brenner, Julia Butt, Noemi Bender, Anna...
  4. forestglip

    Review Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysis, 2025, Toljana et al

    Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysis Karlo Toljana, Albert Aboseifb, Moein Amina Highlights • Amantadine and modafinil are the most studied medications for fatigue in MS. • In a pooled analysis, medications demonstrated...
  5. forestglip

    Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis, 2025, Sebaiti et al

    Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis Mehdi Aoun Sebaiti, Nadia Oubaya, Yannick Gounden, Chloé Samson, Emmanuele Lechapt, Abir Wahab, Alain Creange, Mathieu Hainselin, François-Jérôme Authier Objective...
  6. forestglip

    HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab, 2025, Martín-Martínez et al

    HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab Eva Martín-Martínez, Sara Gil-Perotin, Karen Giménez-Orenga, Lucas Barea-Moya, Elisa Oltra [Line breaks added] Abstract This article summarizes the case of 30-year-old male diagnosed with...
  7. SNT Gatchaman

    Functional neurological disorder in multiple sclerosis: A prospective study, 2025, Cuoco et al.

    Functional neurological disorder in multiple sclerosis: A prospective study Cuoco; Scannapieco; Barra; Giordano; Gregorio; Barone; Erro BACKGROUND There is increasing recognition Functional Neurological disorder (FND) is comorbid with other neurological conditions, but little is known about...
  8. Andy

    Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation 2024 Verma et al

    Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS), the pathophysiology of which remains unclear and for which there is no definitive cure. Antimicrobial peptides (AMPs) are immunomodulatory molecules expressed in various tissues, including the CNS...
  9. forestglip

    Postprandial somnolence in people with multiple sclerosis, 2022, Christmas et al

    Postprandial somnolence in people with multiple sclerosis Tatiana Christmas, Neena Singh, Saul Reyes, Kimberley Allen-Philbey, Gavin Giovannoni Objectives To identify whether people with MS (pwMS) suffer from postprandial somnolence (PPS) more than people without MS (controls), to examine...
  10. forestglip

    Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis, 2024, Salter et al

    Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis Amber Salter, Samantha Lancia, Gary R. Cutter, Robert J. Fox, Ruth Ann Marrie Background and Objectives Infections, including infection with SARS-CoV-2 (COVID-19), could alter the course of multiple...
  11. SNT Gatchaman

    The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study, 2024, Levitz et al

    The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study David Levitz, Anneke Van Der Walt et 39 al BACKGROUND The relationship between coronavirus disease 2019 (COVID-19) infection and multiple sclerosis (MS) relapse and...
  12. Mij

    Broad Analysis of Serum and Intrathecal Antimicrobial Antibodies in Multiple Sclerosis Underscores Unique Role of EBV, 2025, Florence Pache et al

    Abstract Background and Objectives There is a strong link between Epstein-Barr virus (EBV) and multiple sclerosis (MS), but the underlying mechanisms are unclear. Patients with MS typically have a polyspecific intrathecal production of immunoglobulin G (IgG), part of which is directed against...
  13. Dolphin

    12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a RCT, 2024, Jallouli

    https://link.springer.com/article/10.1007/s11011-024-01428-2 12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a randomized controlled trial Research Published: 04 December 2024 Abstract Multiple sclerosis (MS) can induce...
  14. Sly Saint

    SARS-CoV-2 infection and risk of subsequent demyelinating diseases: national register-based cohort study.

    Manuscript has been accepted pendingpublications Covid-19 may raise risk of developing multiple sclerosis
  15. MSEsperanza

    Comparative effectiveness of [CBT], modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS), 2024, Braley et al

    Full title: Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial Background Fatigue is one of the most disabling symptoms reported by people...
  16. Sly Saint

    Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions 2024

    Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Inflammation is gradually compartmentalized and restricted to specific tissue niches such as the lesion rim. However, the precise cell type composition of such niches, their interactions and changes...
  17. Mij

    Accumulation of EVV–induced cross-reactive immune responses is associated with MS, 2024, Hannes Vietzen et al

    In summary, we report that MS patients are hallmarked by an accumulation of immune responses specifically directed against EBV EBNA381–452 and cross-reacting with CNS GlialCAM370–389–, CRYAB2–21–, MBP205–224–, and ANO2135–154–derived epitopes. Although, our findings provide additional insights...
  18. SNT Gatchaman

    Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis, 2024, Rubin et al.

    Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis Martina Rubin; Paolo Preziosa; Monica Margoni; Alessandro Meani; Elisabetta Pagani; Gianluca Corazzolla; Loredana Storelli; Damiano Mistri; Massimo Filippi; Maria A Rocca...
  19. Joan Crawford

    Epstein–Barr virus as a potentiator of autoimmune diseases

    Epstein–Barr virus as a potentiator of autoimmune diseases William H. Robinson, Shady Younis, …Tobias V. Lanz Show authors Nature Reviews Rheumatology (2024)Cite this article Metricsdetails Abstract The Epstein–Barr virus (EBV) is epidemiologically associated with development of autoimmune...
  20. Haveyoutriedyoga

    Chronic fatigue syndrome and multiple sclerosis have reduced craniospinal compliance and dilated pressurized bridging cortical veins, 2024, G. Bateman

    Chronic fatigue syndrome and multiple sclerosis have reduced craniospinal compliance and dilated pressurized bridging cortical veins https://www.sciencedirect.com/science/article/pii/S0306987723002396?via=ihub Abstract Chronic fatigue syndrome (CFS) and multiple sclerosis (MS) share...
Back
Top